Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

855
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
855
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

4.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
4.7K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

2.1K
2.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

3.8K
3.8K
Tumor Progression02:07

Tumor Progression

6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Haplotype-resolved genome architecture mapping uncovers pervasive structural heterogeneity between human homologous chromosomes.

bioRxiv : the preprint server for biology·2026
Same author

Phylogenetic tree inference from single-cell RNA sequencing data with SCITE-RNA.

Genome biology·2026
Same author

Wastewater-based sequencing of respiratory syncytial virus to investigate lineage dynamics and antigenic site mutations: a retrospective genomic epidemiology study.

The Lancet. Microbe·2026
Same author

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Nature cancer·2026
Same author

People are turning to AI chatbots to plug gaps in health information.

Nature·2026
Same author

Author Correction: The dynamics of mutational selection in cutaneous squamous carcinogenesis.

Communications biology·2026
Same journal

Diversification dynamics in the global radiation of gobies.

Systematic biology·2026
Same journal

Correction to: nQMaker: Estimating Time Nonreversible Amino Acid Substitution Models.

Systematic biology·2026
Same journal

Phylogenomic challenges in polyploid-rich lineages: Insights from paralog processing and reticulation methods using the complex genus Packera (Asteraceae: Senecioneae).

Systematic biology·2026
Same journal

An evolving view of phylogenetic biogeography.

Systematic biology·2026
Same journal

Modeling Site-and-Branch-Heterogeneity with GFmix.

Systematic biology·2026
Same journal

Coalescent-based branch length estimation improves dating of species trees.

Systematic biology·2026
See all related articles

Related Experiment Video

Updated: Apr 22, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

5.5K

Cancer evolution: mathematical models and computational inference.

Niko Beerenwinkel1, Roland F Schwarz2, Moritz Gerstung2

  • 1Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland; SIB Swiss Institute of Bioinformatics, 4058 Basel, Switzerland; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, United Kingdom; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, United Kingdom; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB20RE, United Kingdom Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland; SIB Swiss Institute of Bioinformatics, 4058 Basel, Switzerland; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, United Kingdom; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, United Kingdom; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB20RE, United Kingdom niko.beerenwinkel@bsse.ethz.ch.

Systematic Biology
|October 9, 2014
PubMed
Summary
This summary is machine-generated.

Cancer evolves through accumulating mutations, impacting tumor growth and treatment resistance. Evolutionary modeling analyzes tumor dynamics and history, aiding prognosis and predicting therapy outcomes.

Keywords:
Cancercancer progressionevolutionpopulation geneticsprobabilistic graphical models

More Related Videos

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
08:08

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Published on: June 11, 2014

15.2K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

1.1K

Related Experiment Videos

Last Updated: Apr 22, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

5.5K
Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
08:08

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Published on: June 11, 2014

15.2K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

1.1K

Area of Science:

  • Oncology
  • Evolutionary Biology
  • Computational Biology

Background:

  • Cancer is fundamentally a somatic evolutionary process driven by genetic mutations.
  • These mutations fuel tumor growth, progression, immune evasion, and resistance to therapies.
  • Understanding cancer evolution is crucial for effective treatment strategies.

Purpose of the Study:

  • To review current modeling approaches for cancer evolution.
  • To highlight the application of evolutionary theory in analyzing tumor dynamics.
  • To emphasize the prognostic potential of evolutionary modeling in cancer.

Main Methods:

  • Review of population dynamics models for tumor initiation and progression.
  • Application of phylogenetic methods to infer evolutionary relationships among tumor subclones.
  • Utilization of probabilistic graphical models to depict mutation dependencies.

Main Results:

  • Evolutionary modeling provides insights into tumor origin and development.
  • Identified methods allow inference of tumor evolutionary history from molecular data.
  • Modeling approaches address tumor cell population dynamics.

Conclusions:

  • Evolutionary modeling is key to understanding cancer development.
  • These models offer significant prognostic value for disease progression.
  • Predictive capabilities extend to patient response to targeted therapies and interventions.